Pentoxifylline may increase the anticoagulant activities of Lepirudin. Pentoxifylline may increase the anticoagulant activities of Fondaparinux. Pentoxifylline may increase the anticoagulant activities of Ancrod. Pentoxifylline may increase the hypotensive activities of Sitaxentan. Pentoxifylline may increase the hypotensive activities of Bupranolol. Pentoxifylline may increase the antiplatelet activities of Sevoflurane. Pentoxifylline may increase the antiplatelet activities of Ifetroban. Pentoxifylline may increase the anticoagulant activities of Anistreplase. Pentoxifylline may increase the hypotensive activities of Phenoxybenzamine. The metabolism of Pentoxifylline can be decreased when combined with Nevirapine. The serum concentration of Pentoxifylline can be decreased when it is combined with Teriflunomide. Pentoxifylline may increase the antiplatelet activities of Prasugrel. The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Mesalazine. Pentoxifylline may increase the antiplatelet activities of Sarpogrelate. Pentoxifylline may increase the hypotensive activities of Indenolol. Pentoxifylline may increase the anticoagulant activities of Urokinase. Pentoxifylline may increase the hypotensive activities of BQ-123. Pentoxifylline may increase the anticoagulant activities of Dextran 40. The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Aloxiprin. Pentoxifylline may increase the antiplatelet activities of Ifenprodil. Pentoxifylline may increase the anticoagulant activities of Fondaparinux sodium. Pentoxifylline may increase the hypotensive activities of Bendroflumethiazide. Pentoxifylline may increase the antiplatelet activities of Eptifibatide. Pentoxifylline may increase the anticoagulant activities of Edoxaban. Pentoxifylline may increase the anticoagulant activities of Parnaparin. Pentoxifylline may increase the anticoagulant activities of Ardeparin. Pentoxifylline may increase the hypotensive activities of Penbutolol. Pentoxifylline may increase the anticoagulant activities of Bivalirudin. Pentoxifylline may increase the hypotensive activities of Bretylium. Pentoxifylline may increase the anticoagulant activities of Desmoteplase. Pentoxifylline may increase the antiplatelet activities of Tranilast. The metabolism of Pentoxifylline can be decreased when combined with Clotrimazole. Pentoxifylline may increase the hypotensive activities of Clonidine. Pentoxifylline may increase the anticoagulant activities of Dalteparin. The serum concentration of Pentoxifylline can be increased when it is combined with Peginterferon alfa-2b. Pentoxifylline may increase the antiplatelet activities of Beraprost. Pentoxifylline may increase the anticoagulant activities of Dabigatran etexilate. Pentoxifylline may increase the anticoagulant activities of Certoparin. Pentoxifylline may increase the antiplatelet activities of Ticlopidine. The serum concentration of Pentoxifylline can be increased when it is combined with Vemurafenib. The metabolism of Pentoxifylline can be decreased when combined with Tenofovir disoproxil. Pentoxifylline may increase the hypotensive activities of Saprisartan. The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Olsalazine. Pentoxifylline may increase the hypotensive activities of Guanabenz. Pentoxifylline may increase the hypotensive activities of Hexamethonium. Pentoxifylline may increase the hypotensive activities of Bisoprolol. Pentoxifylline may increase the hypotensive activities of Cicletanine. Pentoxifylline may increase the hypotensive activities of Acebutolol. Pentoxifylline may increase the hypotensive activities of Telmisartan. Pentoxifylline may increase the antiplatelet activities of Epinastine. The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Deoxycholic Acid. Pentoxifylline may increase the antiplatelet activities of Triflusal. Pentoxifylline may increase the hypotensive activities of Methyldopa. Pentoxifylline may increase the hypotensive activities of Carvedilol. Pentoxifylline may increase the hypotensive activities of Nicardipine. Pentoxifylline may increase the anticoagulant activities of Fluindione. Pentoxifylline may increase the antiplatelet activities of Ketanserin. Pentoxifylline may increase the hypotensive activities of Hydroflumethiazide. The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline. Pentoxifylline may increase the hypotensive activities of Guanethidine. The serum concentration of Pentoxifylline can be increased when it is combined with Dosulepin. Pentoxifylline may increase the hypotensive activities of Betaxolol. The serum concentration of Dyphylline can be increased when it is combined with Pentoxifylline. Pentoxifylline may increase the hypotensive activities of Minoxidil. Pentoxifylline may increase the hypotensive activities of Pindolol. Pentoxifylline may increase the hypotensive activities of Bethanidine. Pentoxifylline may increase the anticoagulant activities of Ximelagatran. Pentoxifylline may increase the hypotensive activities of Niguldipine. Pentoxifylline may increase the hypotensive activities of Remikiren. Pentoxifylline may increase the hypotensive activities of Indapamide. The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Salicylic acid. Pentoxifylline may increase the anticoagulant activities of Dextran. Pentoxifylline may increase the anticoagulant activities of Tinzaparin. Pentoxifylline may increase the hypotensive activities of Trandolapril. Pentoxifylline may increase the antiplatelet activities of Tirofiban. Glucosamine may increase the antiplatelet activities of Pentoxifylline. The serum concentration of Pentoxifylline can be increased when it is combined with Deferasirox. Pentoxifylline may increase the hypotensive activities of Cilazapril. Pentoxifylline may increase the hypotensive activities of Amlodipine. Pentoxifylline may increase the hypotensive activities of Cyclothiazide. Limaprost may increase the antiplatelet activities of Pentoxifylline. Pentoxifylline may increase the hypotensive activities of Nisoldipine. Pentoxifylline may increase the hypotensive activities of Lercanidipine. Pentoxifylline may increase the antiplatelet activities of Abciximab. Pentoxifylline may increase the antiplatelet activities of Epoprostenol. Pentoxifylline may increase the hypotensive activities of Tetrahydropalmatine. Pentoxifylline may increase the antiplatelet activities of Resveratrol. Pentoxifylline may increase the hypotensive activities of Temocapril. Pentoxifylline may increase the hypotensive activities of Rescinnamine. The risk or severity of adverse effects can be increased when Pentosan Polysulfate is combined with Pentoxifylline. Pentoxifylline may increase the hypotensive activities of Nilvadipine. Pentoxifylline may increase the hypotensive activities of Pargyline. Pentoxifylline may increase the hypotensive activities of Dorzolamide. Pentoxifylline may increase the antiplatelet activities of Tesmilifene. The metabolism of Pentoxifylline can be decreased when combined with Ropinirole. Pentoxifylline may increase the anticoagulant activities of Acenocoumarol. Pentoxifylline may increase the hypotensive activities of Moexipril. Pentoxifylline may increase the anticoagulant activities of Troxerutin. Pentoxifylline may increase the antiplatelet activities of Andrographolide. Pentoxifylline may increase the antiplatelet activities of Defibrotide. Pentoxifylline may increase the anticoagulant activities of Antithrombin III human. The serum concentration of Pentoxifylline can be increased when it is combined with Fluvoxamine. Omega-3 fatty acids may increase the antiplatelet activities of Pentoxifylline. Pentoxifylline may increase the hypotensive activities of Indoramin. Pentoxifylline may increase the antiplatelet activities of Eplivanserin. Pentoxifylline may increase the antiplatelet activities of Trapidil. Pentoxifylline may increase the hypotensive activities of Chlorthalidone. Pentoxifylline may increase the hypotensive activities of Ramipril. Vitamin E may increase the antiplatelet activities of Pentoxifylline. Pentoxifylline may increase the antiplatelet activities of Hydroxytyrosol. Pentoxifylline may increase the antiplatelet activities of Clopidogrel. Pentoxifylline may increase the hypotensive activities of Polythiazide. Pentoxifylline may increase the hypotensive activities of Xylometazoline. Pentoxifylline may increase the hypotensive activities of Nadolol. Pentoxifylline may increase the antiplatelet activities of Anagrelide. Pentoxifylline may increase the hypotensive activities of Chlorothiazide. Pentoxifylline may increase the antiplatelet activities of Azelastine. Pentoxifylline may increase the hypotensive activities of Travoprost. The metabolism of Pentoxifylline can be decreased when combined with Lobeglitazone. Pentoxifylline may increase the hypotensive activities of Candesartan. Pentoxifylline may increase the anticoagulant activities of Danaparoid. Pentoxifylline may increase the anticoagulant activities of Nadroparin. Pentoxifylline may increase the hypotensive activities of Labetalol. Pentoxifylline may increase the hypotensive activities of Candesartan cilexetil. Pentoxifylline may increase the hypotensive activities of Tolazoline. The metabolism of Pentoxifylline can be decreased when combined with Caffeine. Pentoxifylline may increase the anticoagulant activities of Rosiglitazone. Pentoxifylline may increase the anticoagulant activities of Phenindione. Pentoxifylline may increase the hypotensive activities of Talinolol. Pentoxifylline may increase the hypotensive activities of Riociguat.